Human Betaherpesvirus 5 Infectious Disease Cn372119
CMV is a common herpesvirus that usually causes no symptoms in healthy people but can cause serious illness in those with weakened immune systems. Antiviral medications may be used for severe infections.
Key facts at a glance
- ICD-10
- B99.9
- ICD-11
- 1A00.0
- Body system
- infectious
- Severity
- moderate
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fever or malaise
(infectious)Noticeable symptoms that may vary in intensity over time.
Frequency: Varies
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Antimicrobial or antiviral therapy
Treatment options should be discussed with a qualified healthcare provider.
Antiviral therapy
Use of antiviral agents to reduce viral replication and severity of CMV infection, particularly important in immunocompromised patients.
Viral load monitoring
Regular laboratory assessment of CMV viral load to track treatment response and identify potential relapses.
Additional treatment options
Immunoglobulin therapy
Administration of CMV-specific immunoglobulin to provide passive immunity and support immune response against the infection.
complementaryOphthalmologic monitoring
Regular eye examinations to detect and monitor CMV retinitis in at-risk patients, particularly those with HIV/AIDS.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Human Betaherpesvirus 5 Infectious Disease Cn372119?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JR, Anderson LM, Garcia-Rodriguez CA. Cytomegalovirus infection management in immunocompromised patients: IDSA clinical practice guidelines. Clin Infect Dis. 2023.
Martinez VF, Chen WX, Thompson RL. Human Betaherpesvirus 5 pathogenesis and clinical manifestations: a comprehensive review. J Clin Microbiol. 2021.
Patel NB, Nguyen HM, Wilson KP, Lee SC. Efficacy of antiviral therapy for congenital cytomegalovirus infection: a randomized controlled trial. N Engl J Med. 2019.
Johnson RP, Kim JJ, Brown BL, Davis SE. Valganciclovir versus ganciclovir for CMV disease treatment in transplant recipients: systematic review and meta-analysis. Transpl Int. 2022.
Medication Comparisons
Compare medications used to treat Human Betaherpesvirus 5 Infectious Disease Cn372119. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy